,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,UFH group,enoxaparin group,,,,
0,incidence of overall recurrent thromboembolic events during 10 days of treatment,seven of 67,one of 67,NR,NR,P < .002,NR
